Ginkgo biloba has no established safe dose for children, and no major health authority recommends it for pediatric use. While some small studies have tested ginkgo in children and adolescents for specific conditions, the evidence is thin, and the supplement carries real risks that parents should understand before considering it.
No Pediatric Safety Standards Exist
Ginkgo biloba is sold as a dietary supplement, which means it doesn’t go through the same approval process as prescription medications. The FDA has not recognized ginkgo extract as safe even as a food ingredient for the general population, citing a long-term animal study by the National Toxicology Program that found clear evidence of cancer-causing activity in mice and some evidence in rats. That concern applies to adults and children alike, though children’s developing bodies may be more vulnerable to toxic effects.
No regulatory body has set recommended doses specifically for children. The clinical trials that have included younger participants used widely varying amounts, and none were large enough to establish a reliable safety profile. This is a significant gap. Without well-studied pediatric dosing, any amount given to a child is essentially guesswork.
Seeds Are Especially Dangerous
There’s an important distinction between ginkgo leaf extract (the kind sold in capsules and teas) and ginkgo seeds, which are eaten in some traditional cuisines. Raw or roasted ginkgo seeds contain a compound that interferes with vitamin B6 activity in the brain and can trigger seizures, particularly in young children. In one documented case, a 1-year-old girl developed an hour of continuous convulsions after eating a bowl of ginkgo seeds roughly 10 hours earlier. Her seizures required emergency treatment. The Children’s Hospital at Montefiore notes plainly that raw or roasted ginkgo seeds and unprocessed leaves can be toxic.
Standardized leaf extracts sold as supplements go through processing that removes some of the more dangerous compounds. These appear safer in moderate amounts for healthy adults, but “safer” is not the same as “safe for children.”
What the ADHD Research Actually Shows
One of the most common reasons parents look into ginkgo for children is attention and focus. A double-blind, randomized trial tested ginkgo against methylphenidate (the active ingredient in common ADHD medications) in children and adolescents with ADHD. The results were not encouraging for ginkgo. Parents rated ADHD symptoms as improving by about 6.5 points in the ginkgo group compared to nearly 16 points in the methylphenidate group. Teacher ratings showed an even wider gap: less than 1 point of improvement with ginkgo versus 14 points with standard medication. The researchers concluded that ginkgo was significantly less effective.
This doesn’t mean ginkgo did nothing at all, but the effect was small enough that it’s hard to separate from placebo. For a child struggling with ADHD symptoms, ginkgo is not a substitute for proven treatments.
No Evidence It Sharpens Focus in Healthy Kids
Some parents wonder whether ginkgo could give a healthy child a cognitive edge, improving memory or concentration even without a diagnosis. A Cochrane review looked at this question in healthy individuals and found the evidence unconvincing. A 2002 analysis of nine trials concluded there wasn’t sufficient evidence to recommend ginkgo for cognitive enhancement in people without cognitive decline. No studies have specifically tested this in healthy children, so there is no reason to expect a benefit and no data to support the practice.
Bleeding Risk and Drug Interactions
Ginkgo has well-documented blood-thinning effects. It inhibits platelet function, which means it can make bleeding harder to stop. This matters for any child who takes common pain relievers like ibuprofen or other anti-inflammatory drugs, because the combination increases the risk of bleeding events. A large analysis of ginkgo drug interactions found that the most concerning pairings were with blood thinners and NSAIDs (the drug class that includes ibuprofen and naproxen), where ginkgo enhanced the toxic effects and raised bleeding risk.
If your child is scheduled for surgery of any kind, including dental procedures or tonsillectomy, ginkgo should be stopped at least two weeks beforehand. This is the same guideline given to adults by the Mayo Clinic, and it applies because the blood-thinning effect takes time to wear off. Interactions with anticonvulsants and ADHD stimulants haven’t been specifically studied, which is itself a concern. Unknown interactions are not the same as no interactions.
Limited Use in Vitiligo
One area where ginkgo has shown a small but real effect is vitiligo, a condition that causes patches of skin to lose pigment. In a randomized trial, 40 mg of ginkgo taken three times daily for six months stopped the spread of vitiligo in 20 out of 25 participants, and 10 of those saw significant repigmentation of 75% or more. A smaller pilot study using 60 mg twice daily for 12 weeks found that vitiligo stopped progressing in all 12 participants, with an average repigmentation of 15%.
These studies included participants as young as 12, so there is at least some data in older adolescents. However, these were small trials, and the results haven’t been replicated at scale. For a child or teenager with vitiligo, this is worth discussing with a dermatologist who can weigh ginkgo’s modest benefits against its risks in the context of your child’s full health picture.
The Bottom Line on Safety
Standardized ginkgo leaf extract is generally tolerated by healthy adults in low doses over short periods, but that finding does not extend to children. No pediatric dosing guidelines exist, the FDA hasn’t deemed it safe even as a food additive, ginkgo seeds pose a seizure risk especially in young children, and the supplement interacts with common medications. The conditions where ginkgo shows the most promise in younger populations, like vitiligo, involve modest effects that need to be weighed carefully against these unknowns. For cognitive enhancement or ADHD, the evidence simply isn’t there.